Ying Yuan, Md

This early-phase study tested a personalized immunotherapy (neoantigen vaccine) in 6 patients with stage III colorectal or non-small cell lung cancer after they completed standard surgery and chemotherapy. The goal was to see if the vaccine is safe and can help prevent the cancer…